The Europe cartilage degeneration market is expected to reach US$ 3,365.09 million by 2027 from US$ 2,463.16 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027.
The increasing prevalence of sports injuries and obesity is driving the growth of cartilage degeneration market in the region. However, the high cost of cartilage therapies and lack of reimbursement scenario are the major factors hindering the market growth in Europe.
Degeneration of cartilage can lead to pain and chronic inflammation in joints of the human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.
According to a study published by British Journal of Sports Medicine, an estimated 3.1% of adults in Germany suffer from a sports injury, with an annual injury rate of 5.6%, ranking sports injuries as the second most common type of accident. Further, most common injuries observed among children and teenagers are sprains and strains. Dislocations, distortions, and/or torn ligaments make up 60% of all sports injuries, followed by fractures (18%), contusions, surface wounds, or open wounds (12%). An increasing number of incidents of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period.
Additionally, European Home and Leisure Accidents Surveillance System (EHLASS), and official German statistics indicate that fatal sports accidents throughout the European Union (EU) and Germany account for only 1% of all fatalities. Also, two-thirds of the injuries are reported in soccer, handball, basketball, and volleyball. The growing number of participants in sports leads to increasing possibilities of sports injuries. Therefore, the rising prevalence of cartilage injuries will eventually accelerate the growth of the cartilage degeneration market in Europe by 2027.
The European economy is severely affected due to the exponential rise in the COVID-19 cases. The Medical Device Regulation (MDR) requires manufacturers to conduct Post Market Clinical Follow-Up (PMCF) studies to demonstrate the continued safety and performance of their devices. This is expected to impact the product launch and ongoing clinical trials of medical devices, thereby hampering the sales and the market growth. Also, disrupted supply chains, extended lockdowns, and canceling of other medical procedures have adversely affected the growth of the cartilage degeneration market in Europe.
Rest of Europe Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE CARTILAGE DEGENERATION MARKET SEGMENTATION
By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
By Application
- Knee
- Hips
- Other
By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation
Europe Cartilage Degeneration Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 2,463.16 Million |
Market Size by 2027 | US$ 3,365.09 Million |
Global CAGR (2020 - 2027) | 4.1% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Procedure Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - Europe Cartilage Degeneration Market
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation


